1. Home
  2. CYBN vs NVX Comparison

CYBN vs NVX Comparison

Compare CYBN & NVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYBN
  • NVX
  • Stock Information
  • Founded
  • CYBN 2019
  • NVX 2012
  • Country
  • CYBN Canada
  • NVX Australia
  • Employees
  • CYBN N/A
  • NVX N/A
  • Industry
  • CYBN Pharmaceuticals and Biotechnology
  • NVX Industrial Machinery/Components
  • Sector
  • CYBN Health Care
  • NVX Miscellaneous
  • Exchange
  • CYBN Nasdaq
  • NVX Nasdaq
  • Market Cap
  • CYBN 180.4M
  • NVX 176.8M
  • IPO Year
  • CYBN N/A
  • NVX N/A
  • Fundamental
  • Price
  • CYBN $7.61
  • NVX $1.10
  • Analyst Decision
  • CYBN Strong Buy
  • NVX
  • Analyst Count
  • CYBN 4
  • NVX 0
  • Target Price
  • CYBN $85.00
  • NVX N/A
  • AVG Volume (30 Days)
  • CYBN 387.1K
  • NVX 59.8K
  • Earning Date
  • CYBN 08-07-2025
  • NVX 01-01-0001
  • Dividend Yield
  • CYBN N/A
  • NVX N/A
  • EPS Growth
  • CYBN N/A
  • NVX N/A
  • EPS
  • CYBN N/A
  • NVX N/A
  • Revenue
  • CYBN N/A
  • NVX $5,854,424.00
  • Revenue This Year
  • CYBN N/A
  • NVX $66.66
  • Revenue Next Year
  • CYBN N/A
  • NVX $2,366.64
  • P/E Ratio
  • CYBN N/A
  • NVX N/A
  • Revenue Growth
  • CYBN N/A
  • NVX N/A
  • 52 Week Low
  • CYBN $4.81
  • NVX $0.81
  • 52 Week High
  • CYBN $13.88
  • NVX $2.73
  • Technical
  • Relative Strength Index (RSI)
  • CYBN 46.51
  • NVX 46.92
  • Support Level
  • CYBN $7.35
  • NVX $1.06
  • Resistance Level
  • CYBN $7.85
  • NVX $1.21
  • Average True Range (ATR)
  • CYBN 0.60
  • NVX 0.06
  • MACD
  • CYBN -0.10
  • NVX 0.01
  • Stochastic Oscillator
  • CYBN 18.20
  • NVX 42.14

About CYBN Cybin Inc.

Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The company is focused on advancing psychedelic-based therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions.

About NVX NOVONIX Limited American Depository Shares

NOVONIX Ltd operates in the lithium-ion battery industry. The company has three operating segments namely Graphite Exploration, Battery Technology, and Battery Materials. Graphite Exploration segment is engaged in the exploration and development of high-grade flake graphite deposits. The Battery Technology segment develops battery cell testing equipment and carries out research and development in battery development. The Battery Materials segment develops and manufactures battery anode materials. The Battery Technology segment generates maximum revenue for the company.

Share on Social Networks: